Advances in High Sensitivity Protein Detection from Biofluids and the Potential in Early Diagnosis and Therapeutic Monitoring

Join this 57-minute panel webinar featuring three expert speakers who explore cutting-edge advances in high-sensitivity protein detection from biological fluids and their applications in early disease diagnosis and therapeutic monitoring. Learn about the challenges of detecting low-abundance proteins in biofluids, where highly abundant proteins typically mask important biomarkers involved in key biochemical cascades. Discover how the NULISA™ Platform revolutionizes traditional immunoassays by dramatically improving sensitivity and enabling highly multiplexed quantification of both low- and high-abundance proteins from just 10μL samples. Explore the capabilities of the NULISAseq™ Inflammation Panel 250, which provides comprehensive coverage of cytokines and immune response markers to identify disease progression signatures, understand disease heterogeneity, and predict the development of serious reactions. Gain insights into how circulating proteins in biofluids serve as ideal non-invasive biomarkers for early disease detection and participate in a live Q&A session with the presenting experts.